Machine Learning Median Technologies Announces Completion of the Q-Submission Phase with the FDA for its iBiopsy Lung… Business Wire Mar 1, 2023 Median Technologies announces that the Company has received feedback from the United States Food and Drug Administration (FDA) regarding the…
Machine Learning Delfi Diagnostics Initiates 15,000-Patient Prospective Lung Cancer Screening Trial AIT News Desk May 10, 2022 Delfi Diagnostics, a pioneering developer of next generation high performance, affordable liquid biopsy tests for early cancer detection, has enrolled…
Life Sciences Eon Launches Centralized Management to Fully Manage Every Aspect of an Early Detection Lung Cancer… AIT News Desk Nov 3, 2020 The healthtech leader empowers facilities to offload resource-intensive tasks to a team of experts. Eon, a Denver-based healthtech leader, recently…